Profits growing faster than sales. Since 2022: revenue +14%, operating profit +63%.
Since 2022, HealthStream's revenue grew 14% while operating profit grew 63%: each extra dollar of sales is adding more profit.
Cash flow well above reported profit. Free cash flow is 3.3× reported profit.
Free cash flow is 3.3× reported profit. Large non-cash charges, such as depreciation, amortization or stock-based pay, reduce reported profit without using cash.
Annual revenue rose 5 years in a row. Fiscal-year revenue rose from $245M in 2020 to $304M in 2025.
HealthStream's fiscal-year revenue rose in each of the five years to 2025, from $245M to $304M.
Since last quarter: No major changeValuation also moves with the share price every day.
Why it changed since the Oct 27, 2026 close: Score 52 → 54
Share price -7.3%+2
Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.
Yahoo Finance fallback · no standard SEC debt tagReported value33% base weight · Z-score 0.90Sector median: 0.2215 · MAD: 0.2039
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about HealthStream
Is HealthStream getting weaker?
Its latest SEC filing (Aug 6, 2026) showed no major changes. Its overall score is unchanged at 54/100 since Oct 28, 2026.
How is HealthStream valued vs its peers?
Priced about in line with its peers. Valuation scores 54/100 against 1,393 healthcare peers.
Is HealthStream growing?
At about the same pace as its peers. Growth scores 48/100 against 1,393 healthcare peers.
How profitable is HealthStream?
About as profitable as its peers. Profitability scores 58/100 against 1,393 healthcare peers.Return on assets 4.1% vs a peer median of 1.7% (stronger than 67% of peers).Return on assets 4.1% vs peers 1.7% (stronger than 67% of peers).
How risky is HealthStream?
Moderate risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings.Debt / equity 0.04× vs a peer median of 0.22× (stronger than 79% of peers).Debt / equity 0.04× vs peers 0.22× (stronger than 79% of peers).Current ratio 1.06× vs a peer median of 2.59× (weaker than 88% of peers).Current ratio 1.06× vs peers 2.59× (weaker than 88% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Quarter ended Jun 30, 2026 · filed Aug 6, 2026 · compared with the quarter ended Mar 31, 2026
No major changes
Previous quarter
Latest quarter
Change
Revenue (12 months)
311.8M USD
321.1M USD
+3.0%
Net income (12 months)
19.9M USD
21.2M USD
+6.4%
Operating margin
7.5%
8.0%
+0.5 pts
Free cash flow (12 months)
60.0M USD
69.8M USD
+16.4%
Cash
48.7M USD
46.2M USD
−5.2%
Shares outstanding
29.2M
29.2M
+0.1%
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Industry valuation context
Sector: Healthcare · 301 companies
Valuations in Healthcare are within their usual range since 2016.
52% of months since 2016 were valued lower than now.
19% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values +8% and earnings +24% (medians): earnings grew faster than prices.
Median price-to-sales is +63% vs the whole market, against a usual +119%.
2016Shaded: most expensive fifth of its range2026
Shown for Healthcare: too few Health Information Services companies have a long enough history of their own.
Earnings-based measures are left out for now because many companies in Healthcare are losing money.
Describes valuations since 2016; it does not predict prices. US companies worth $1B+, from SEC filings and month-end prices, as of Aug 2026. Today's companies and industry labels are used throughout. Measured on sales and free cash flow yields. How this works
Financials
Fiscal years from SEC annual filings · change vs the prior year
Key ratios
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Change
Operating margin
3.1%
4.7%
5.7%
7.3%
6.7%
▼ 0.6 pts
Net margin
2.3%
4.5%
5.5%
6.9%
6.0%
▼ 0.8 pts
Return on assets (ROA)
1.2%
2.4%
3.0%
3.9%
3.5%
▼ 0.4 pts
Return on equity (ROE)
1.7%
3.6%
4.5%
5.6%
5.2%
▼ 0.4 pts
Free cash flow margin
15.2%
18.5%
22.1%
19.3%
19.6%
▲ 0.3 pts
Current ratio
1.06×
0.98×
1.10×
1.32×
0.96×
▼ 27%
HSTM price history
Price history is added with the daily price update and will appear after the next one.